Literature DB >> 3103536

Biosynthetic preparation of L-[13C]- and [15N]glutamate by Brevibacterium flavum.

T E Walker, R E London.   

Abstract

The biosynthesis of isotopically labeled L-glutamic acid by the microorganism Brevibacterium flavum was studied with a variety of carbon-13-enriched precursors. The purpose of this study was twofold: to develop techniques for the efficient preparation of labeled L-glutamate with a variety of useful labeling patterns which can be used for other metabolic studies, and to better understand the metabolic events leading to label scrambling in these strains. B. flavum, which is used commercially for the production of monosodium glutamate, has the capability of utilizing glucose or acetate as a sole carbon source, an important criterion from the standpoint of developing labeling strategies. Unfortunately, singly labeled glucose precursors lead to excessive isotopic dilution which reduces their usefulness. Studies with [3-13C]pyruvate indicate that this problem can in principle be overcome by using labeled three-carbon precursors; however, conditions could not be found which would lead to an acceptable yield of isotopically labeled L-glutamate. In contrast, [1-13C]- or [2-13C]acetate provides relatively inexpensive, readily available precursors for the production of selectively labeled, highly enriched L-glutamate. The preparation of L-[15N]glutamate from [15N]ammonium sulfate was carried out and is a very effective labeling strategy. Analysis of the isotopic distribution in labeled glutamate provides details about the metabolic pathways in these interesting organisms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3103536      PMCID: PMC203609          DOI: 10.1128/aem.53.1.92-98.1987

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  7 in total

1.  Cellular permeability and extracellular formation of glutamic acid in Brevibacterium flavum.

Authors:  I SHIIO; S I OTSUKA; N KATSUYA
Journal:  J Biochem       Date:  1963-05       Impact factor: 3.387

2.  Simple enzymatic procedure for preparation of 15N-labeled L-glutamic acid.

Authors:  O Bojan; M Bologa; G Niac; N Palibroda; E Vargha; O Bârzu
Journal:  Anal Biochem       Date:  1980-01-01       Impact factor: 3.365

3.  Biosynthesis of trehalose by Brevibacterium flavum: use of long range 13C-13C coupling data to characterize triose phosphate isomerase activity.

Authors:  R E London; T E Walker
Journal:  Biosci Rep       Date:  1985-06       Impact factor: 3.840

4.  13C nuclear magnetic resonance studies of the biosynthesis by Microbacterium ammoniaphilum of L-glutamate selectively enriched with carbon-13.

Authors:  T E Walker; C H Han; V H Kollman; R E London; N A Matwiyoff
Journal:  J Biol Chem       Date:  1982-02-10       Impact factor: 5.157

5.  Determination of flux through the branch point of two metabolic cycles. The tricarboxylic acid cycle and the glyoxylate shunt.

Authors:  K Walsh; D E Koshland
Journal:  J Biol Chem       Date:  1984-08-10       Impact factor: 5.157

6.  Effect of biotin on the bacterial formation of glutamic acid. I. Glutamate formation and cellular premeability of amino acids.

Authors:  I SHIIO; S I OTSUKA; M TAKAHASHI
Journal:  J Biochem       Date:  1962-01       Impact factor: 3.387

7.  Biosynthetic production of 13C-labeled amino acids with site-specific enrichment.

Authors:  D M LeMaster; J E Cronan
Journal:  J Biol Chem       Date:  1982-02-10       Impact factor: 5.157

  7 in total
  2 in total

1.  PQQ: biosynthetic studies in Methylobacterium AM1 and Hyphomicrobium X using specific 13C labeling and NMR.

Authors:  D R Houck; J L Hanners; C J Unkefer; M A van Kleef; J A Duine
Journal:  Antonie Van Leeuwenhoek       Date:  1989-05       Impact factor: 2.271

Review 2.  Microbial Upgrading of Acetate into Value-Added Products-Examining Microbial Diversity, Bioenergetic Constraints and Metabolic Engineering Approaches.

Authors:  Regina Kutscha; Stefan Pflügl
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.